Skip to main content
Q

QuantaMatrix Incorporated — Investor Relations & Filings

Ticker · 317690 ISIN · KR7317690006 KO Manufacturing
Filings indexed 155 across all filing types
Latest filing 2023-12-15 Regulatory Filings
Country KR South Korea
Listing KO 317690

About QuantaMatrix Incorporated

https://www.quantamatrix.com/

QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory announcement of the administrative procedure for the meeting. Given it is a standard regulatory notification that does not fit into specific categories like 'AGM-R' (which implies presentation materials) or 'PSI' (which implies proxy solicitation materials), it is best classified as a general regulatory filing.
2023-12-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for QuantaMatrix, covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial data, business operations, management discussion, and organizational information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Quantamatrix) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, the counterparty (Argenta), the product (dRAST), and the region (Poland). Since this is a specific operational announcement regarding a business contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-10-26 Korean
소송등의판결ㆍ결정(신주발행무효확인)
Legal Proceedings Report Classification · 1% confidence The document is a formal disclosure regarding a court judgment ('소송 등의 판결ㆍ결정') concerning a lawsuit ('신주발행무효확인'). It details the court's decision, the parties involved, and the legal outcome. Since it specifically addresses a legal proceeding and its resolution, it falls under the 'Legal Proceedings Report' category.
2023-10-16 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for QuantaMatrix, covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, management discussion, and organizational structure. According to the definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) containing actual financial statements and analysis is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-14 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for QuantaMatrix, covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, management discussion, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.